Literature DB >> 28815795

Routine detection of serum antidesmocollin autoantibodies is only useful in patients with atypical pemphigus.

Swantje Mindorf1, Inga M Dettmann1, Stine Krüger2, Tarek Fuhrmann2, Kristin Rentzsch1, Ingolf Karl2, Christian Probst1, Lars Komorowski1, Kai Fechner1, Nina van Beek3, Susanne Lemcke2,4, Miklós Sárdy5, Christine Bangert6, Sandrine Benoit7, Takashi Hashimoto8, Detlef Zillikens3, Hendri H Pas9, Marcel F Jonkman9, Winfried Stöcker1, Enno Schmidt2,3.   

Abstract

Autoantibodies against the 3 desmocollin (Dsc; Dsc1-Dsc3) isoforms have been described in different pemphigus variants. Here, we developed state-of-the-art detection systems for serum anti-Dsc1, Dsc2 and Dsc1 IgG and IgA. These assays were applied in 5 different cohorts including pemphigus vulgaris (PV) patients with compatible direct immunofluorescence (IF) microscopy but no reactivity against desmogleins 1 and 3 (n = 24) and sera from patients with autoimmune blistering diseases with positive direct IF microscopy taken at the time of diagnosis (n = 749). We found that detection of anti-Dsc serum reactivity is not helpful in the routine diagnosis of PV, pemphigus foliaceus and paraneoplastic pemphigus but may be valuable in pemphigus vegetans.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  atypical; autoantibody; diagnosis; foliaceus; vulgaris vegetans

Mesh:

Substances:

Year:  2017        PMID: 28815795     DOI: 10.1111/exd.13409

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  12 in total

Review 1.  Pemphigus-A Disease of Desmosome Dysfunction Caused by Multiple Mechanisms.

Authors:  Volker Spindler; Jens Waschke
Journal:  Front Immunol       Date:  2018-02-01       Impact factor: 7.561

Review 2.  Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris.

Authors:  Kyle T Amber; Manuel Valdebran; Sergei A Grando
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

3.  Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.

Authors:  Maxi Hofrichter; Jenny Dworschak; Shirin Emtenani; Jana Langenhan; Fanny Weiß; Lars Komorowski; Detlef Zillikens; Winfried Stöcker; Christian Probst; Enno Schmidt; Stephanie Goletz
Journal:  Front Immunol       Date:  2018-09-03       Impact factor: 7.561

4.  Development of a Desmocollin-3 Active Mouse Model Recapitulating Human Atypical Pemphigus.

Authors:  Roberta Lotti; Claudio Giacinto Atene; Alessandra Marconi; Giulia Di Rocco; L Reggiani Bonetti; Tommaso Zanocco Marani; Carlo Pincelli
Journal:  Front Immunol       Date:  2019-06-19       Impact factor: 7.561

Review 5.  Pemphigus: Current and Future Therapeutic Strategies.

Authors:  Dario Didona; Roberto Maglie; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 6.  Serological Diagnosis of Autoimmune Bullous Skin Diseases.

Authors:  Sandra Saschenbrecker; Ingolf Karl; Lars Komorowski; Christian Probst; Cornelia Dähnrich; Kai Fechner; Winfried Stöcker; Wolfgang Schlumberger
Journal:  Front Immunol       Date:  2019-08-20       Impact factor: 7.561

Review 7.  Milestones in Personalized Medicine in Pemphigus and Pemphigoid.

Authors:  Katja Bieber; Khalaf Kridin; Shirin Emtenani; Katharina Boch; Enno Schmidt; Ralf J Ludwig
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

8.  Keratinocyte Binding Assay Identifies Anti-Desmosomal Pemphigus Antibodies Where Other Tests Are Negative.

Authors:  Federica Giurdanella; Albertine M Nijenhuis; Gilles F H Diercks; Marcel F Jonkman; Hendri H Pas
Journal:  Front Immunol       Date:  2018-04-24       Impact factor: 7.561

Review 9.  Diagnosis of Autoimmune Blistering Diseases.

Authors:  Mareike Witte; Detlef Zillikens; Enno Schmidt
Journal:  Front Med (Lausanne)       Date:  2018-11-02

10.  Anti-Desmocollin Autoantibodies in Autoimmune Blistering Diseases.

Authors:  Xavier Bosch-Amate; Pilar Iranzo; Marta Ivars; José Manuel Mascaró Galy; Agustín España
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.